$73.59
0.21[0.29%]
At close: Apr 26
$73.59
0[0.00%]
After Hours: 4:00PM EDT
Acadia Healthcare Co
(NASDAQ:ACHC)Acadia Healthcare Co Stock (NASDAQ:ACHC), Analyst Ratings, Price Targets, Predictions
Acadia Healthcare Co Inc has a consensus price target of $85.55, established from looking at the 51 latest analyst ratings. The last 3 analyst ratings were released from Deutsche Bank, Mizuho, and Barclays on April 25, 2024, March 6, 2024, and March 6, 2024. With an average price target of $84.67 between Deutsche Bank, Mizuho, and Barclays, there's an implied 15.05% upside for Acadia Healthcare Co Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Deutsche Bank
Mizuho
Barclays
Cantor Fitzgerald
RBC Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Acadia Healthcare Co
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/25/2024 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | -4.88% | Deutsche Bank | Pito Chickering | → $70 | Upgrade | Sell → Hold | Get Alert |
| 03/06/2024 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 14.15% | Mizuho | Ann Hynes | $77 → $84 | Maintains | Neutral | Get Alert |
| 03/06/2024 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 35.89% | Barclays | Andrew Mok | → $100 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 22.3% | Cantor Fitzgerald | Sarah James | → $90 | Reiterates | Neutral → Neutral | Get Alert |
| 03/04/2024 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 27.73% | RBC Capital | Ben Hendrix | → $94 | Reiterates | Outperform → Outperform | Get Alert |
| 03/01/2024 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 37.25% | TD Cowen | Gary Taylor | $86 → $101 | Maintains | Outperform | Get Alert |
| 02/28/2024 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 38.61% | UBS | Andrew Mok | $88 → $102 | Maintains | Buy | Get Alert |
| 01/05/2024 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 25.02% | Stephens & Co. | Scott Fidel | → $92 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/07/2023 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 27.73% | RBC Capital | Ben Hendrix | $99 → $94 | Maintains | Outperform | Get Alert |
| 09/14/2023 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 15.5% | Cantor Fitzgerald | Joseph France | $83 → $85 | Maintains | Neutral | Get Alert |
| 07/31/2023 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 34.53% | RBC Capital | Ben Hendrix | $93 → $99 | Maintains | Outperform | Get Alert |
| 07/31/2023 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 29.09% | Credit Suisse | A.J. Rice | → $95 | Reiterates | Outperform → Outperform | Get Alert |
| 07/12/2023 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 12.79% | Stephens & Co. | Scott Fidel | → $83 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/02/2023 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 12.79% | Stephens & Co. | Scott Fidel | → $83 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 05/04/2023 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 29.09% | Credit Suisse | A.J. Rice | $93 → $95 | Maintains | Outperform | Get Alert |
| 04/28/2023 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 29.09% | Credit Suisse | Jonathan Yong | $93 → $95 | Maintains | Outperform | Get Alert |
| 04/27/2023 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 19.58% | Stephens & Co. | Scott Fidel | → $88 | Reiterates | → Equal-Weight | Get Alert |
| 04/24/2023 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | 25.02% | UBS | Andrew Mok | $96 → $92 | Maintains | Buy | Get Alert |
| 04/20/2023 | ACHC | Buy Now | Acadia Healthcare Co | $73.59 | -14.39% | Deutsche Bank | Pito Chickering | $75 → $63 | Downgrade | Hold → Sell | Get Alert |
FAQ
What is the target price for Acadia Healthcare Co (ACHC)?
The latest price target for Acadia Healthcare Co (NASDAQ: ACHC) was reported by Deutsche Bank on April 25, 2024. The analyst firm set a price target for $70.00 expecting ACHC to fall to within 12 months (a possible -4.88% downside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Acadia Healthcare Co (ACHC)?
The latest analyst rating for Acadia Healthcare Co (NASDAQ: ACHC) was provided by Deutsche Bank, and Acadia Healthcare Co upgraded their hold rating.
When was the last upgrade for Acadia Healthcare Co (ACHC)?
The last upgrade for Acadia Healthcare Co Inc happened on April 25, 2024 when Deutsche Bank raised their price target to $70. Deutsche Bank previously had a sell for Acadia Healthcare Co Inc.
When was the last downgrade for Acadia Healthcare Co (ACHC)?
The last downgrade for Acadia Healthcare Co Inc happened on April 20, 2023 when Deutsche Bank changed their price target from $75 to $63 for Acadia Healthcare Co Inc.
When is the next analyst rating going to be posted or updated for Acadia Healthcare Co (ACHC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acadia Healthcare Co, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acadia Healthcare Co was filed on April 25, 2024 so you should expect the next rating to be made available sometime around April 25, 2025.
Is the Analyst Rating Acadia Healthcare Co (ACHC) correct?
While ratings are subjective and will change, the latest Acadia Healthcare Co (ACHC) rating was a upgraded with a price target of $0.00 to $70.00. The current price Acadia Healthcare Co (ACHC) is trading at is $73.59, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.